Weaver, M. J., Stump, S., Campbell, M. J., Backos, D. S., Li, C., Reigan, P., . . . Natale, N. R. (2020). 10-N-heterocylic aryl-isoxazole-amides (AIMs) have robust anti-tumor activity against breast and brain cancer cell lines and useful fluorescence properties. Bioorg Med Chem.

Weaver, Matthew J., Sascha Stump, Michael J. Campbell, Donald S. Backos, Chun Li, Philip Reigan, Earle Adams, Howard D. Beall, and Nicholas R. Natale. "10-N-heterocylic Aryl-isoxazole-amides (AIMs) Have Robust Anti-tumor Activity against Breast and Brain Cancer Cell Lines and Useful Fluorescence Properties." Bioorg Med Chem 2020.

Weaver, Matthew J., et al. "10-N-heterocylic Aryl-isoxazole-amides (AIMs) Have Robust Anti-tumor Activity against Breast and Brain Cancer Cell Lines and Useful Fluorescence Properties." Bioorg Med Chem 2020.